Skip to main content
Update Location

My Location

Update your location to show providers, locations, and services closest to you.

Enter a zip code
Or
Select a campus/region

Michael R Bubb, MD

Rheumatologist (Joints & Arthritis Specialist)

Photo of Michael R Bubb

Research at a glance

Top areas of exploration

  • Actins , 37 publications
  • Amino Acid Sequence , 18 publications
  • Microfilament Proteins , 18 publications
  • Protein Binding , 13 publications

Research activity

78 publications

3,919 citations

Why is this important?

Active clinical trials

OCEAN
Investigator
Michael R Bubb
Status
Accepting Candidates
ARGX-113-2007

This study's purpose is to measure the treatment response from efgartigimod PH20 SC compared with placebo in participants with Idiopathic Inflammatory Myopathy (IIM). Participants with the IIM subtypes of dermatomyositis (DM), immune-mediated…

Investigator
Michael R Bubb
Status
Accepting Candidates
Ages
18 Years - N/A
Sexes
All
PVT-2201-301

This is a phase 3, multicenter, randomized, placebo-controlled, double-blind study of treatment with brepocitinib (TYK2/JAK1 inhibitor) in adults with dermatomyositis (DM). The primary objective of this study is to assess the efficacy of two dose…

Investigator
Michael R Bubb
Status
Accepting Candidates
Ages
18 Years - 75 Years
Sexes
All

My publications

78 publications

2019

Excess Deaths Upon Cessation of Xanthine Oxidase Inhibitor Treatment-Data From the Cardiovascular Safety of Febuxostat and Allopurinol in Patients With Gout and Cardiovascular Morbidities Trial: Comment on the Article by Choi et al.

Arthritis & rheumatology (Hoboken, N.J.)

PubMed Publisher's site

2018

Does Digital Rectal Examination Reduce Subsequent Hospitalizations and Endoscopies or Vice Versa?

The American journal of medicine

PubMed Publisher's site

2018

Efficacy of Warfarin Anticoagulation and Incident Dementia: Does Cognitive Impairment Reduce Efficacy?

Mayo Clinic proceedings

PubMed Publisher's site

2016

In Reply I-Risk of Disseminated Disease in Immunosuppressed Patients Receiving Live Zoster Vaccine.

Mayo Clinic proceedings

PubMed Publisher's site

2016

Muscarinic type 3 receptor autoantibodies are associated with anti-SSA/Ro autoantibodies in Sjögren's syndrome.

Journal of immunological methods

PubMed Publisher's site